Targeted Inactivation of Kinesin-1 in Pancreatic β-Cells In Vivo Leads to Insulin Secretory Deficiency

OBJECTIVE: Suppression of Kinesin-1 by antisense oligonucleotides, or overexpression of dominant-negative acting kinesin heavy chain, has been reported to affect the sustained phase of glucose-stimulated insulin secretion in β-cells in vitro. In this study, we examined the in vivo physiological role...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ju, Wang, Zai, Cheng, Qianni, Lin, Raozhou, Zhang, Xin-Mei, Leung, Po Sing, Copeland, Neal G., Jenkins, Nancy A., Yao, Kwok-Ming, Huang, Jian-Dong
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012189/
https://www.ncbi.nlm.nih.gov/pubmed/20870970
http://dx.doi.org/10.2337/db09-1078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012189/
https://www.ncbi.nlm.nih.gov/pubmed/20870970
http://dx.doi.org/10.2337/db09-1078

Ejemplares similares